Cathie's Ark Logo
undefined Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
November 19, 2024
BUY164.198k0.0357%ARKK
November 18, 2024
BUY115.222k0.0255%ARKK
November 15, 2024
BUY23.256k0.0052%ARKK
October 24, 2024
BUY178.395k0.0522%ARKK
October 18, 2024
BUY133.009k0.0503%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
0.04%
🏋🏿‍♂️Weight Rank In ARKK🌏Country
18🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds
143

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA